Cubist Pharmaceuticals Becomes First Company to Implement Integrated Reprints Desk Document Delivery and QUOSA Scientific Literature Workflow Solution

Thursday, December 10, 2009 News on IT in Healthcare
Email Print This Page Comment
Font : A-A+



SANTA MONICA, Calif. and WALTHAM, Mass., Dec. 10 Reprints Desk, Inc., and QUOSA, Inc., today announced that Cubist Pharmaceuticals has become the first shared customer to activate integration between Reprints Desk's STM Document Delivery service with QUOSA's Virtual Library, which facilitates copyright-compliant article archiving and scientific literature re-use. The integrated solution features integration with Rightsphere, the rights advisory and management tool from Copyright Clearance Center (CCC), which already integrates independently with both Reprints Desk and QUOSA.

"The integration of QUOSA's powerful solution for archiving and sharing scientific journal articles with Reprints Desk's ultra-rapid document delivery service was a logical collaboration for delivering the efficiency and compliance benefits we've been seeking to enhance our eLiterature services," said A. Amyas Huston, Senior Manager of Medical Communications at Cubist. "With QUOSA already deployed and Reprints Desk delivery not requiring any platform fees or any IT information technology involvement from Cubist, the implementation within our workflow processes was fast and seamless."

Lexington MA-based Cubist Pharmaceuticals has been a QUOSA customer and a Reprints Desk customer since 2007. QUOSA serves a large and rapidly growing subscriber-base at leading pharmaceutical, biotechnology and other life-science companies, with solutions for efficiently managing and monitoring scientific literature. Reprints Desk earned the top ranking overall and in every category in the 2008 Document Delivery Best Practices and Vendor Scorecard by analyst and advisory firm Outsell, Inc., and scored a 97% customer satisfaction rating in Dun & Bradstreet's 2009 Open Ratings survey of existing Reprints Desk customers.

For more information about Reprints Desk and its STM Document Delivery service, visit the Reprints Desk website online at www.reprintsdesk.com. For additional information about QUOSA's solutions for efficiently managing and monitoring scientific literature and the QUOSA Virtual Library, visit www.quosa.com.

About QUOSA®

QUOSA Inc. is a specialist software company focused on literature management workflows and archives, which include full-text articles and patents. With a large and rapidly growing subscriber-base at leading pharmaceutical, biotechnology and other life-science companies, and in research and medical centers, QUOSA's applications are used to compress the time to insight and action across the key functions of the innovation enterprise. For more information about QUOSA, please visit the website at www.quosa.com.

About Reprints Desk®

Reprints Desk, Inc. (www.reprintsdesk.com) is a business software and information services company that simplifies how research-intensive companies and other organizations procure, manage and share journal articles and other copyright-protected content. The company's content workflow and compliance solutions help customers effectively use peer-reviewed literature in research, regulatory submissions, and product promotions. A channel supplier for more than 100 scientific, technical, and medical (STM) publishers, Reprints Desk earned the #1 ranking in the 2008 Document Delivery Vendor Scorecard by Outsell, Inc., and currently serves companies in life sciences, energy, aerospace, industrial products, consumer packaged goods, food and beverages, information technology, legal, and government. Reprints Desk is a Derycz Scientific company. For more information about Reprints Desk, contact Ian Palmer at +1 (707) 658-1931.

Public and Media Relations Contacts:------------------------------------Ian Palmer, Head of MarketingReprints Desk, Inc. | +1 707.658.1931ipalmer@reprintsdesk.com

SOURCE Reprints Desk, Inc.


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook